首页> 外国专利> METHOD FOR SCREENING EPILEPTIC OR COGNITIVE IMPAIRMENT TREATING AGENT USING KV4.1

METHOD FOR SCREENING EPILEPTIC OR COGNITIVE IMPAIRMENT TREATING AGENT USING KV4.1

机译:使用KV4.1筛选癫痫或认知障碍治疗剂的方法

摘要

The present invention relates to a method for screening an epileptic or cognitive impairment treating agent, and to a kit for screening an epileptic or cognitive impairment treating agent, wherein the kit includes a means for measuring an activity of a potassium channel, Kv4.1, in a nerve cell expressing the potassium channel, Kv4.1. The method comprises the steps of: treating an epileptic or cognitive impairment treating agent candidate material on a nerve cell expressing a potassium channel, Kv4.1; measuring an activity or an expression amount of the potassium channel, Kv4.1, in a nerve cell treated by the epileptic or cognitive impairment treating agent candidate material in the previous step; and determining the corresponding epileptic or cognitive impairment treating agent candidate material as an epileptic or cognitive impairment treating agent when the activity or the expression amount of the potassium channel, Kv4.1, measured in the previous step increases more than a control group nerve cell which is not treated by an epileptic or cognitive impairment treating agent candidate material. Moreover, the present invention relates to a method for inspecting an effect of an epileptic or cognitive impairment treating agent by measuring an activity or an expression amount of a potassium channel, Kv4.1, in a nerve cell expressing the potassium channel, Kv4.1, and to an effect inspection kit including a means for measuring an activity of a potassium channel, Kv4.1, in a nerve cell expressing the potassium channel, Kv4.1. The potassium channel, Kv4.1, of the present invention has independently adjusted activity and expression with respect to an epileptic or cognitive impairment symptom irrespective of another Kv4 channel, so a new epileptic or cognitive impairment treating agent can be screened by measuring the same. Also, effects of a conventional epileptic or cognitive impairment treating agent can be easily and effectively inspected.;COPYRIGHT KIPO 2017
机译:本发明涉及一种用于筛选癫痫或认知障碍治疗剂的方法,以及一种用于筛选癫痫或认知障碍治疗剂的试剂盒,其中该试剂盒包括用于测量钾通道Kv4.1活性的工具。在表达钾通道Kv4.1的神经细胞中该方法包括以下步骤:在表达钾通道Kv4.1的神经细胞上治疗癫痫或认知障碍治疗剂候选物质;在上一步中,测量由癫痫或认知障碍治疗剂候选物质治疗的神经细胞中钾通道Kv4.1的活性或表达量;并在前一步骤中测量的钾通道Kv4.1的活性或表达量比对照组神经细胞增加更多时,确定相应的癫痫或认知障碍治疗剂候选材料为癫痫或认知障碍治疗剂。未被癫痫或认知障碍治疗剂候选物质治疗。此外,本发明涉及通过测量表达钾通道Kv4.1的神经细胞中钾通道Kv4.1的活性或表达量来检查癫痫或认知障碍治疗剂的作用的方法。以及效果检查工具包,该工具包包括用于测量表达钾通道Kv4.1的神经细胞中钾通道Kv4.1活性的装置。本发明的钾通道Kv4.1相对于癫痫或认知障碍症状具有独立调节的活性和表达,而与另一Kv4通道无关,因此可以通过测量其来筛选新的癫痫或认知障碍治疗剂。此外,可以轻松有效地检查常规癫痫或认知障碍治疗剂的效果。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号